18.47
前日終値:
$18.35
開ける:
$18.47
24時間の取引高:
161
Relative Volume:
0.04
時価総額:
$442.21M
収益:
$1.70M
当期純損益:
$-47.01M
株価収益率:
-10.86
EPS:
-1.7
ネットキャッシュフロー:
$-157.28M
1週間 パフォーマンス:
-2.53%
1か月 パフォーマンス:
+4.58%
6か月 パフォーマンス:
-14.31%
1年 パフォーマンス:
-19.69%
Puretech Health Plc Adr Stock (PRTC) Company Profile
PRTC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PRTC
Puretech Health Plc Adr
|
18.47 | 442.21M | 1.70M | -47.01M | -157.28M | -1.70 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-09-09 | 再開されました | Leerink Partners | Outperform |
Puretech Health Plc Adr (PRTC) 最新ニュース
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
PureTech Health stock hits 52-week low at $16.81 amid market shifts By Investing.com - Investing.com South Africa
PureTech Health stock hits 52-week low at $16.81 amid market shifts - Investing.com India
FDA fast tracks PureTech's leukemia treatment - Investing.com
PureTech to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $175.96 - Defense World
Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Nasdaq
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
Puretech Health Plc Adr (PRTC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):